Login Register Cart 0
Generic placeholder image

Current Cardiology Reviews

Editor-in-Chief

ISSN (Print): 1573-403X
ISSN (Online): 1875-6557

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
General Review Article

Endothelial Dysfunction and Coronary Vasoreactivity - A Review of the History, Physiology, Diagnostic Techniques, and Clinical Relevance

Author(s): Tharusha Gunawardena*, Ioannis Merinopoulos, Upul Wickramarachchi, Vassilios Vassiliou and Simon Eccleshall

Volume 17, Issue 1, 2021

Published on: 18 June, 2020

Page: [85 - 100] Pages: 16

DOI: 10.2174/1573403X16666200618161942

Price: $65

Abstract

The fervency for advancement and evolution in percutaneous coronary intervention has revolutionised the treatment of coronary artery disease. Historically, the focus of the interventional cardiologist was directed at the restoration of luminal patency of the major epicardial coronary arteries, yet whilst this approach is evolving with much greater utilisation of physiological assessment, it often neglects consideration of the role of the coronary microcirculation, which has been shown to clearly influence prognosis. In this review, we explore the narrative of the coronary circulation as more than just a simple conduit for blood but an organ with functional significance. We review organisation and physiology of the coronary circulation, as well as the current methods and techniques used to examine it. We discuss the studies exploring coronary artery endothelial function, appreciating that coronary artery disease occurs on a spectrum of disorder and that percutaneous coronary intervention has a latent effect on the coronary circulation with long-term consequences. It is concluded that greater recognition of the coronary artery endothelium and mechanisms of the coronary circulation should further guide revascularisation strategies.

Keywords: Drug coated balloons, endothelial function, vasoreactivity testing, vasomotion, bioresorbable scaffolds, drug eluting stents, microvascular angina, MINOCA, coronary microcirculation, angina, acute coronary syndrome.

Graphical Abstract

[1]
Gimbrone MA. Guillermo. HHS Public Access. J HHS Public Access 2017; 4(11): 620-36.
[2]
Shechter M, Matetzky S, Prasad M, et al. Endothelial function predicts 1-year adverse clinical outcome in patients hospitalized in the emergency department chest pain unit. Int J Cardiol 2017; 240: 14-9.
[http://dx.doi.org/10.1016/j.ijcard.2017.04.101] [PMID: 28477961]
[3]
von Mering GO, Arant CB, Wessel TR, et al. National Heart, Lung, and Blood Institute. Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: Results from the National Heart, Lung, and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation 2004; 109(6): 722-5.
[http://dx.doi.org/10.1161/01.CIR.0000115525.92645.16] [PMID: 14970106]
[4]
AlBadri A, Bairey Merz CN, Johnson BD, et al. Impact of abnormal coronary reactivity on long-term clinical outcomes in women. J Am Coll Cardiol 2019; 73(6): 684-93.
[http://dx.doi.org/10.1016/j.jacc.2018.11.040] [PMID: 30765035]
[5]
Katz AM, Katz PB. Diseases of the heart in the works of Hippocrates. Br Heart J 1962; 24: 257-64.
[http://dx.doi.org/10.1136/hrt.24.3.257] [PMID: 14454369]
[6]
Khan IA, Mehta NJ. Initial historical descriptions of the angina pectoris. J Emerg Med 2002; 22(3): 295-8.
[http://dx.doi.org/10.1016/S0736-4679(01)00489-9] [PMID: 11932097]
[7]
Lanzer C, Lanzer P. Re: Angina pectoris revisited; Exertional angina preceded Martin Luther’s last stretch of a final journey. Eur Heart J 2016; 37(33): 2570.
[http://dx.doi.org/10.1093/eurheartj/ehw320] [PMID: 27609104]
[8]
Bedford DE. Book review: The history of coronary artery disease by J.O. Leibowitz, London. Wellcome Institute of the History of Medicine. Med Hist 1971; 15(2): 195-6.
[http://dx.doi.org/10.1017/S002572730001646X]
[9]
Fye WB. Edward Jenner. Clin Cardiol 1994; 17(11): 634-5.
[http://dx.doi.org/10.1002/clc.4960171115] [PMID: 7834941]
[10]
Olszewski TM. James Herrick (1861-1954): Consultant physician and cardiologist. J Med Biogr 2018; 26(2): 132-6.
[http://dx.doi.org/10.1177/0967772017745701] [PMID: 29405852]
[11]
Smilowitz NR, Feit F. The history of primary angioplasty and stenting for acute myocardial infarction. Curr Cardiol Rep 2016; 18(1): 5.
[http://dx.doi.org/10.1007/s11886-015-0681-x] [PMID: 26699632]
[12]
Mueller RL, Sanborn TA. The history of interventional cardiology: Cardiac catheterization, angioplasty, and related interventions. Am Heart J 1995; 129(1): 146-72.
[http://dx.doi.org/10.1016/0002-8703(95)90055-1] [PMID: 7817908]
[13]
Crea F, Camici PG, Bairey Merz CN. Coronary microvascular dysfunction: An update. Eur Heart J 2014; 35(17): 1101-11.
[http://dx.doi.org/10.1093/eurheartj/eht513] [PMID: 24366916]
[14]
Van der Heiden K, Gijsen FJ, Narracott A, et al. The effects of stenting on shear stress: Relevance to endothelial injury and repair. Cardiovasc Res 2013; 99(2): 269-75.
[http://dx.doi.org/10.1093/cvr/cvt090] [PMID: 23592806]
[15]
Cheng TO. History of coronary artery bypass surgery--half of a century of progress. Int J Cardiol 2012; 157(1): 1-2.
[http://dx.doi.org/10.1016/j.ijcard.2012.02.018] [PMID: 22425221]
[16]
Ford TJ, Corcoran D, Berry C. Stable coronary syndromes: Pathophysiology, diagnostic advances and therapeutic need. Heart 2018; 104(4): 284-92.
[http://dx.doi.org/10.1136/heartjnl-2017-311446] [PMID: 29030424]
[17]
Shaw J, Anderson T. Coronary endothelial dysfunction in non-obstructive coronary artery disease: Risk, pathogenesis, diagnosis and therapy. Vasc Med 2016; 21(2): 146-55.
[http://dx.doi.org/10.1177/1358863X15618268] [PMID: 26675331]
[18]
Loffler ABJ. HHS Public Access. Curr Cardiol Rep 2016; 8(5): 583-92.
[http://dx.doi.org/10.1002/aur.1474.Replication]
[19]
Grayson J, Davidson JW, Fitzgerald-Finch A, Scott C. The functional morphology of the coronary microcirculation in the dog. Microvasc Res 1974; 8(1): 20-43.
[http://dx.doi.org/10.1016/0026-2862(74)90061-2] [PMID: 4213442]
[20]
Marinescu M, Loffler A, Ouellette M, Smith L, Kramer C, Bourque J. Coronary microvascular dysfunction and microvascular angina: A systematic review of therapies. JACC Cardiovasc Imaging 2015; 8(2): 210-20.
[http://dx.doi.org/10.1016/j.jcmg.2014.12.008] [PMID: 25677893]
[21]
Cannon RO III, Cattau EL Jr, Yakshe PN, et al. Coronary flow reserve, esophageal motility, and chest pain in patients with angiographically normal coronary arteries. Am J Med 1990; 88(3): 217-22.
[http://dx.doi.org/10.1016/0002-9343(90)90145-4] [PMID: 2309738]
[22]
Papanicolaou MN, Califf RM, Hlatky MA, et al. Prognostic implications of angiographically normal and insignificantly narrowed coronary arteries. Am J Cardiol 1986; 58(13): 1181-7.
[http://dx.doi.org/10.1016/0002-9149(86)90378-4] [PMID: 3788805]
[23]
Cannon RO III, Quyyumi AA, Schenke WH, et al. Abnormal cardiac sensitivity in patients with chest pain and normal coronary arteries. J Am Coll Cardiol 1990; 16(6): 1359-66.
[http://dx.doi.org/10.1016/0735-1097(90)90377-2] [PMID: 2229787]
[24]
Cannon RO III. Microvascular angina and the continuing dilemma of chest pain with normal coronary angiograms. J Am Coll Cardiol 2009; 54(10): 877-85.
[http://dx.doi.org/10.1016/j.jacc.2009.03.080] [PMID: 19712795]
[25]
Furchgott RF, Zawadzki JVFFR. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288(5789): 373-6.
[http://dx.doi.org/10.1038/288373a0] [PMID: 6253831]
[26]
Widlansky ME, Gokce N, Keaney JF Jr, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 2003; 42(7): 1149-60.
[http://dx.doi.org/10.1016/S0735-1097(03)00994-X] [PMID: 14522472]
[27]
Park K-HP and WJ. Vascular disease: Types of vascular disease 2015; 1213-25.
[http://dx.doi.org/10.3346/jkms.2015.30.9.1213]
[28]
Kim JW, Suh SY, Choi CU, et al. Six-month comparison of coronary endothelial dysfunction associated with sirolimus-eluting stent vs. Paclitaxel-eluting stent. JACC Cardiovasc Interv 2008; 1(1): 65-71.
[http://dx.doi.org/10.1016/j.jcin.2007.11.002] [PMID: 19393147]
[29]
Selthofer-Relatic K, Mihalj M, Kibel A, et al. Coronary microcirculatory dysfunction in human cardiomyopathies: A pathologic and pathophysiologic review. Cardiol Rev 2017; 25(4): 165-78.
[http://dx.doi.org/10.1097/CRD.0000000000000140] [PMID: 28574936]
[30]
Ross R. Inflammation or atherogenesis. N Engl J Med 1999; 340(2): 115-26.
[http://dx.doi.org/10.1056/NEJM199901143400207] [PMID: 9887164]
[31]
Crea F, Lanza GA, Camici PG. Coronary microvascular dysfunction 2013.
[32]
Mann DL, Zipes DP, Libby P, Bonow RO, Braunwald E. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. Single Volume 2014.
[33]
Gould KL, Johnson NP. Coronary physiology beyond coronary flow reserve in microvascular angina: JACC State-of-the-Art Review. J Am Coll Cardiol 2018; 72(21): 2642-62.
[http://dx.doi.org/10.1016/j.jacc.2018.07.106] [PMID: 30466522]
[34]
Fonseca DA, Antunes PE, Cotrim MD. The Morphology, physiology and pathophysiology of coronary microcirculation. microcirculation revisited - from molecules to clinical practice 2016.
[http://dx.doi.org/10.5772/64537]
[35]
Fonseca DA, Antunes PE, Cotrim MD. Endothelium-dependent vasoactivity of the human internal mammary artery. Coron Artery Dis 2014; 25(3): 266-74.
[http://dx.doi.org/10.1097/MCA.0000000000000097] [PMID: 24584032]
[36]
Morris PD, Ryan D, Morton AC, et al. Virtual fractional flow reserve from coronary angiography: modeling the significance of coronary lesions: Results from the VIRTU-1 (VIRTUal Fractional Flow Reserve From Coronary Angiography) study. JACC Cardiovasc Interv 2013; 6(2): 149-57.
[http://dx.doi.org/10.1016/j.jcin.2012.08.024] [PMID: 23428006]
[37]
Ghiadoni L, Salvetti M, Muiesan ML, Taddei S. Evaluation of endothelial function by flow mediated dilation: Methodological issues and clinical importance. High Blood Press Cardiovasc Prev 2015; 22(1): 17-22.
[http://dx.doi.org/10.1007/s40292-014-0047-2] [PMID: 24619864]
[38]
Crea F. Coronary microvascular obstruction--a puzzle with many pieces. N Engl J Med 2015; 372(15): 1464-5.
[http://dx.doi.org/10.1056/NEJMe1501882] [PMID: 25853751]
[39]
Laughlin MH, Bowles DK, Duncker DJ. The coronary circulation in exercise training. Am J Physiol Heart Circ Physiol 2012; 302(1): H10-23.
[http://dx.doi.org/10.1152/ajpheart.00574.2011] [PMID: 21984538]
[40]
Karabucak B, Walsch H, Jou YT, Simchon S, Kim S. The role of endothelial nitric oxide in the Substance P induced vasodilation in bovine dental pulp. J Endod 2005; 31(10): 733-6.
[http://dx.doi.org/10.1097/01.don.0000157988.13010.25] [PMID: 16186752]
[41]
Brainin P, Frestad D, Prescott E. The prognostic value of coronary endothelial and microvascular dysfunction in subjects with normal or non-obstructive coronary artery disease: A systematic review and meta-analysis. Int J Cardiol 2018; 254: 1-9.
[http://dx.doi.org/10.1016/j.ijcard.2017.10.052] [PMID: 29407076]
[42]
Reese DE, Mikawa T, Bader DM. Development of the coronary vessel system. Circ Res 2002; 91(9): 761-8.
[http://dx.doi.org/10.1161/01.RES.0000038961.53759.3C] [PMID: 12411389]
[43]
Herscovici R, Sedlak T, Wei J, Pepine CJ, Handberg E, Bairey Merz CN. Ischemia and no obstructive coronary artery disease (INOCA): What is the risk? J Am Heart Assoc 2018; 7(17): e008868.
[http://dx.doi.org/10.1161/JAHA.118.008868] [PMID: 30371178]
[44]
Merz CNB, Kelsey SF, Pepine CJ, et al. The Women’s Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report. J Am Coll Cardiol 1999; 33(6): 1453-61.
[http://dx.doi.org/10.1016/S0735-1097(99)00082-0] [PMID: 10334408]
[45]
Wieneke H, von Birgelen C, Haude M, et al. Determinants of coronary blood flow in humans: Quantification by intracoronary Doppler and ultrasound. J Appl Physiol 2005; 98(3): 1076-82.
[http://dx.doi.org/10.1152/japplphysiol.00724.2004] [PMID: 15516363]
[46]
Beltrame JF, Crea F, Camici P. Advances in coronary microvascular dysfunction. Hear Lung Circ 2008.
[47]
Sheng Y, Zhu L. The crosstalk between autonomic nervous system and blood vessels. Int J Physiol Pathophysiol Pharmacol 2018; 10(1): 17-28.
[PMID: 29593847]
[48]
Zanatta E, Famoso G, Boscain F, et al. Nailfold avascular score and coronary microvascular dysfunction in systemic sclerosis: A newsworthy association. Autoimmun Rev 2019; 18(2): 177-83.
[http://dx.doi.org/10.1016/j.autrev.2018.09.002] [PMID: 30572139]
[49]
Guzzardi MA, Iozzo P. Fatty heart, cardiac damage, and inflammation. Rev Diabet Stud 2011; 8(3): 403-17.
[http://dx.doi.org/10.1900/RDS.2011.8.403] [PMID: 22262077]
[50]
Majerczak J, Grandys M, Frołow M, et al. Age-dependent impairment in endothelial function and arterial stiffness in former high class male athletes is no different to that in men with no history of physical training. J Am Heart Assoc 2019; 8(18): e012670.
[http://dx.doi.org/10.1161/JAHA.119.012670] [PMID: 31512551]
[51]
Colbert JF, Schmidt EP. Endothelial and microcirculatory function and dysfunction in sepsis. Clin Chest Med 2016; 37(2): 263-75.
[http://dx.doi.org/10.1016/j.ccm.2016.01.009] [PMID: 27229643]
[52]
Curzen NP, Griffiths MJD, Evans TW. Role of the endothelium in modulating the vascular response to sepsis. Clin Sci (Lond) 1994; 86(4): 359-74.
[http://dx.doi.org/10.1042/cs0860359] [PMID: 8168329]
[53]
Agrawal S, Mehta PK, Bairey Merz CN. Cardiac Syndrome X: Update. Heart Fail Clin 2016; 12(1): 141-56.
[http://dx.doi.org/10.1016/j.hfc.2015.08.012] [PMID: 26567981]
[54]
Majidinia M, Rasmi Y, Khadem Ansari MH, Seyed-Mohammadzad M, Saboory E, Shirpoor A. Metoprolol improves endothelial function in patients with cardiac syndrome X. Iran J Pharm Res 2016; 15(3): 561-6.
[PMID: 27980592]
[55]
Petersen SE, Jerosch-Herold M, Hudsmith LE, et al. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: New insights from multiparametric magnetic resonance imaging. Circulation 2007; 115(18): 2418-25.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.106.657023] [PMID: 17452610]
[56]
Fernlund E, Schlegel TT, Platonov PG, Carlson J, Carlsson M, Liuba P. Peripheral microvascular function is altered in young individuals at risk for hypertrophic cardiomyopathy and correlates with myocardial diastolic function. Am J Physiol - Hear Circ Physiol 2015; 308(11): H1351-8.
[http://dx.doi.org/10.1152/ajpheart.00714.2014]
[57]
Gómez-Hospital JA, Tenas MS, Cequier Fillat A, et al. Endothelial function in coronary segments previously treated with balloon angioplasty. Rev Esp Cardiol 2000; 53(11): 1467-73.
[PMID: 11084005]
[58]
Vassanelli C, Menegatti G, Zanolla L, Molinari J, Zanotto G, Zardini P. Coronary vasoconstriction in response to acetylcholine after balloon angioplasty: Possible role of endothelial dysfunction. Coron Artery Dis 1994; 5(12): 979-86.
[http://dx.doi.org/10.1097/00019501-199412000-00004] [PMID: 7728298]
[59]
Plass CA, Sabdyusheva-Litschauer I, Bernhart A, et al. Time course of endothelium-dependent and -independent coronary vasomotor response to coronary balloons and stents. Comparison of plain and drug-eluting balloons and stents. JACC Cardiovasc Interv 2012; 5(7): 741-51.
[http://dx.doi.org/10.1016/j.jcin.2012.03.021] [PMID: 22814779]
[60]
Ahmadi N, Ruiz-Garcia J, Hajsadeghi F, et al. Impaired coronary artery distensibility is an endothelium-dependent process and is associated with vulnerable plaque composition. Clin Physiol Funct Imaging 2016; 36(4): 261-8.
[http://dx.doi.org/10.1111/cpf.12220] [PMID: 25524149]
[61]
Higashi Y, Maruhashi T, Noma K, Kihara Y. Oxidative stress and endothelial dysfunction: Clinical evidence and therapeutic implications. Trends Cardiovasc Med 2014; 24(4): 165-9.
[http://dx.doi.org/10.1016/j.tcm.2013.12.001] [PMID: 24373981]
[62]
Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000; 101(9): 948-54.
[http://dx.doi.org/10.1161/01.CIR.101.9.948] [PMID: 10704159]
[63]
el-Tamimi H, Davies GJ, Crea F, Maseri A. Response of human coronary arteries to acetylcholine after injury by coronary angioplasty. J Am Coll Cardiol 1993; 21(5): 1152-7.
[http://dx.doi.org/10.1016/0735-1097(93)90239-W] [PMID: 8459070]
[64]
Patik JC, Christmas KM, Hurr C, Brothers RM. Impaired endothelium independent vasodilation in the cutaneous microvasculature of young obese adults. Microvasc Res 2016; 104: 63-8.
[http://dx.doi.org/10.1016/j.mvr.2015.11.007] [PMID: 26631530]
[65]
Niccoli G, Montone RA, Lanza GA, Crea F. Angina after percutaneous coronary intervention: The need for precision medicine. Int J Cardiol 2017; 248: 14-9.
[http://dx.doi.org/10.1016/j.ijcard.2017.07.105] [PMID: 28807510]
[66]
Feng J, Liu Y, Singh AK, et al. Effects of diabetes and cardiopulmonary bypass on expression of adherens junction proteins in human peripheral tissue. United States: Surgery 2017.
[http://dx.doi.org/10.1016/j.surg.2016.08.057]
[67]
Feng J, Chu LM, Dobrilovic N, Liu Y, Singh AK, Sellke FW. Decreased coronary microvascular reactivity after cardioplegic arrest in patients with uncontrolled diabetes mellitus. United States: Surg 2012.
[http://dx.doi.org/10.1016/j.surg.2012.04.009]
[68]
Ford TJ, Rocchiccioli P, Good R, et al. Systemic microvascular dysfunction in microvascular and vasospastic angina. Eur Heart J 2018; 39(46): 4086-97.
[http://dx.doi.org/10.1093/eurheartj/ehy529] [PMID: 30165438]
[69]
House EH, Berry C, Balachandran KP, et al. Structure of the coronary circulation. Eur Heart J 2014; 28(3): 278-91.
[http://dx.doi.org/10.1093/eurheartj/ehl446]
[70]
Stone PH, Saito S, Takahashi S, et al. PREDICTION Investigators. Prediction of progression of coronary artery disease and clinical outcomes using vascular profiling of endothelial shear stress and arterial plaque characteristics: the PREDICTION Study. Circulation 2012; 126(2): 172-81.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.112.096438] [PMID: 22723305]
[71]
Koskinas KC, Chatzizisis YS, Antoniadis AP, Giannoglou GD. Role of endothelial shear stress in stent restenosis and thrombosis: Pathophysiologic mechanisms and implications for clinical translation. J Am Coll Cardiol 2012; 59(15): 1337-49.
[http://dx.doi.org/10.1016/j.jacc.2011.10.903] [PMID: 22480478]
[72]
Diamond SL, Sharefkin JB, Dieffenbach C, Frasier-Scott K, McIntire LV, Eskin SG. Tissue plasminogen activator messenger RNA levels increase in cultured human endothelial cells exposed to laminar shear stress. J Cell Physiol 1990; 143(2): 364-71.
[http://dx.doi.org/10.1002/jcp.1041430222] [PMID: 2110169]
[73]
Ohyama K, Matsumoto Y, Amamizu H, et al. Association of coronary perivascular adipose tissue inflammation and drug-eluting stent-induced coronary hyperconstricting responses in pigs: 18F-fluorodeoxyglucose positron emission tomography imaging study. Arterioscler Thromb Vasc Biol 2017; 37(9): 1757-64.
[http://dx.doi.org/10.1161/ATVBAHA.117.309843] [PMID: 28751570]
[74]
Maruhashi T, Kihara Y, Higashi Y. Diabetes and endothelial dysfunction. Diabetes and Aging-related Complications 2017.
[75]
Page AV, Liles WC. 2012 Virulence0152 2013; 507-16.
[http://dx.doi.org/10.4161/viru.24530]
[76]
Bhatta A, Yao L, Xu Z, et al. Obesity-induced vascular dysfunction and arterial stiffening requires endothelial cell arginase 1. Cardiovasc Res 2017; 113(13): 1664-76.
[http://dx.doi.org/10.1093/cvr/cvx164] [PMID: 29048462]
[77]
Borgi L, McMullan C, Wohlhueter A, Curhan GC, Fisher ND, Forman JP. Effect of Vitamin D on endothelial function: A randomized, double-blind, placebo-controlled trial. Am J Hypertens 2017; 30(2): 124-9.
[http://dx.doi.org/10.1093/ajh/hpw135] [PMID: 28077419]
[78]
Juni RP, Duckers HJ, Vanhoutte PM, Virmani R, Moens AL. Oxidative stress and pathological changes after coronary artery interventions. J Am Coll Cardiol 2013; 61(14): 1471-81.
[http://dx.doi.org/10.1016/j.jacc.2012.11.068] [PMID: 23500310]
[79]
Zalos G, Finkel T, Hill JM, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. Obstet Gynecol Surv 2004; 58(7): 467-8.
[http://dx.doi.org/10.1097/01.ogx.0000074096.62998.d7]
[80]
Schächinger V, Zeiher AM. Atherogenesis--recent insights into basic mechanisms and their clinical impact. Nephrol Dial Transplant 2002; 17(12): 2055-64.
[http://dx.doi.org/10.1093/ndt/17.12.2055] [PMID: 12454211]
[81]
Reriani M, Flammer AJ, Duhé J, et al. Coronary endothelial function testing may improve long-term quality of life in subjects with microvascular coronary endothelial dysfunction. Open Heart 2019; 6(1): e000870.
[http://dx.doi.org/10.1136/openhrt-2018-000870] [PMID: 30815267]
[82]
Tagliamonte E, Rigo F, Cirillo T, et al. Effects of ranolazine on noninvasive coronary flow reserve in patients with myocardial ischemia but without obstructive coronary artery disease. Echocardiography 2015; 32(3): 516-21.
[http://dx.doi.org/10.1111/echo.12674] [PMID: 25041234]
[83]
Villano A, Di Franco A, Nerla R, et al. Effects of ivabradine and ranolazine in patients with microvascular angina pectoris. Am J Cardiol 2013; 112(1): 8-13.
[http://dx.doi.org/10.1016/j.amjcard.2013.02.045] [PMID: 23558043]
[84]
Leenders GJ, Smeets MB, van den Boomen M, et al. Statins promote cardiac infarct healing by modulating endothelial barrier function revealed by contrast-enhanced magnetic resonance imaging. Arterioscler Thromb Vasc Biol 2018; 38(1): 186-94.
[http://dx.doi.org/10.1161/ATVBAHA.117.310339] [PMID: 29146749]
[85]
Hamasaki S, Tei C. Effect of coronary endothelial function on outcomes in patients undergoing percutaneous coronary intervention. J Cardiol 2011; 57(3): 231-8.
[http://dx.doi.org/10.1016/j.jjcc.2011.02.003] [PMID: 21398093]
[86]
Sandhu K, Mamas M, Butler R. Endothelial progenitor cells: Exploring the pleiotropic effects of statins. World J Cardiol 2017; 9(1): 1-13.
[http://dx.doi.org/10.4330/wjc.v9.i1.1] [PMID: 28163831]
[87]
Durante A. Role of no reflow and microvascular obstruction in the prognostic stratification of STEMI patients. Anatol J Cardiol 2018; 19(5): 346-9.
[http://dx.doi.org/10.14744/AnatolJCardiol.2018.62343] [PMID: 29537970]
[88]
Karimianpour A, Maran A. Advances in coronary no-reflow phenomenon-a contemporary review. Curr Atheroscler Rep 2018; 20(9): 44.
[http://dx.doi.org/10.1007/s11883-018-0747-5] [PMID: 29974260]
[89]
Reffelmann T, Kloner RA. The “no-reflow” phenomenon: Basic science and clinical correlates. Heart 2002; 87(2): 162-8.
[http://dx.doi.org/10.1136/heart.87.2.162] [PMID: 11796561]
[90]
Kloner RA, Ganote CE, Jennings RB. The “no-reflow” phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974; 54(6): 1496-508.
[http://dx.doi.org/10.1172/JCI107898] [PMID: 4140198]
[91]
Hausenloy DJ, Chilian W, Crea F, et al. The coronary circulation in acute myocardial ischaemia/reperfusion injury: A target for cardioprotection. Cardiovasc Res 2018.
[http://dx.doi.org/10.1093/cvr/cvy286] [PMID: 30428011]
[92]
Kloner RA, King KS, Harrington MG. No-reflow phenomenon in the heart and brain. Am J Physiol - Hear Circ Physiol 2018; 315(3): H550-62.
[http://dx.doi.org/10.1152/ajpheart.00183.2018]
[93]
De Bruyne B, Oldroyd KG, Pijls NHJ. Microvascular (Dys)function and clinical outcome in stable coronary disease. J Am Coll Cardiol 2016; 67(10): 1170-2.
[http://dx.doi.org/10.1016/j.jacc.2015.11.066] [PMID: 26965537]
[94]
Layland J, Carrick D, Lee M, Oldroyd K, Berry C. Adenosine: physiology, pharmacology, and clinical applications. JACC Cardiovasc Interv 2014; 7(6): 581-91.
[http://dx.doi.org/10.1016/j.jcin.2014.02.009] [PMID: 24835328]
[95]
Doucette JW, Corl PD, Payne HM, et al. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation 1992; 85(5): 1899-911.
[http://dx.doi.org/10.1161/01.CIR.85.5.1899] [PMID: 1572046]
[96]
AlBadri A, Wei J, Mehta PK, et al. Acetylcholine vs. cold pressor testing for evaluation of coronary endothelial function. PLoS One 2017; 12(2): e0172538.
[http://dx.doi.org/10.1371/journal.pone.0172538] [PMID: 28207868]
[97]
Horigome M, Kumazaki S, Hattori N, et al. Noninvasive evaluation of coronary endothelial function following sirolimus-eluting stent implantation by using positron emission tomography. Cardiology 2009; 114(3): 157-63.
[http://dx.doi.org/10.1159/000226093] [PMID: 19556789]
[98]
Stuijfzand WJ, Schumacher SP, Driessen RS, et al. Myocardial blood flow and coronary flow reserve during 3 years following bioresorbable vascular scaffold vs. metallic drug-eluting stent implantation: The VANISH trial. JACC Cardiovasc Interv 2019; 12(10): 967-79.
[http://dx.doi.org/10.1016/j.jcin.2019.03.004] [PMID: 31029616]
[99]
Walborn A, Rondina M, Mosier M, et al. Diagnostic approach to patients with stable angina and no obstructive coronary arteries. J Hypertens 2019; 25(4): 1460-7.
[http://dx.doi.org/10.15420/ecr.2019.22.2]
[100]
Lanza GA, Camici PG, Galiuto L, et al. Gruppo di Studio di Fisiopatologia Coronarica e Microcircolazione, Società Italiana di Cardiologia. Methods to investigate coronary microvascular function in clinical practice. J Cardiovasc Med (Hagerstown) 2013; 14(1): 1-18.
[http://dx.doi.org/10.2459/JCM.0b013e328351680f] [PMID: 23222188]
[101]
Lanza GA. Diagnostic approach to patients with stable angina and no obstructive coronary arteries. Eur Cardiol 2019; 14(2): 97-102.
[http://dx.doi.org/10.15420/ecr.2019.22.2] [PMID: 31360230]
[102]
Hofma SH, van der Giessen WJ, van Dalen BM, et al. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J 2006; 27(2): 166-70.
[http://dx.doi.org/10.1093/eurheartj/ehi571] [PMID: 16249221]
[103]
McKavanagh P, Zawadowski G, Ahmed N, Kutryk M. The evolution of coronary stents. Expert Rev Cardiovasc Ther 2018; 16(3): 219-28.
[http://dx.doi.org/10.1080/14779072.2018.1435274] [PMID: 29381087]
[104]
Merinopoulos I, Wickramarachchi U, Wardley J, et al. Day case discharge of patients treated with drug coated balloon only angioplasty for de novo coronary artery disease: A single center experience. Catheter Cardiovasc Interv 2020; 95(1): 105-8.
[http://dx.doi.org/10.1002/ccd.28217] [PMID: 30957384]
[105]
Iqbal J, Gunn J, Serruys PW. Coronary stents: historical development, current status and future directions. Br Med Bull 2013; 106: 193-211.
[http://dx.doi.org/10.1093/bmb/ldt009] [PMID: 23532779]
[106]
Nawarskas JJ, Osborn LA. Paclitaxel-eluting stents in coronary artery disease. Am J Health Syst Pharm 2005; 62(21): 2241-51.
[http://dx.doi.org/10.2146/ajhp040621] [PMID: 16239414]
[107]
Scheller B, Speck U, Abramjuk C, Bernhardt U, Böhm M, Nickenig G. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 2004; 110(7): 810-4.
[http://dx.doi.org/10.1161/01.CIR.0000138929.71660.E0] [PMID: 15302790]
[108]
Sotomi Y, Suwannasom P, Tenekecioglu E, et al. Differential aspects between cobalt-chromium everolimus drug-eluting stent and absorb everolimus bioresorbable vascular scaffold: from bench to clinical use. Expert Rev Cardiovasc Ther 2015; 13(10): 1127-45.
[http://dx.doi.org/10.1586/14779072.2015.1089172] [PMID: 26401921]
[109]
Brugaletta S, Cequier A, Alfonso F, et al. MAGnesium-based bioresorbable scaffold and vasomotor function in patients with acute ST segment elevation myocardial infarction: The MAGSTEMI trial: Rationale and design. Catheter Cardiovasc Interv 2019; 93(1): 64-70.
[http://dx.doi.org/10.1002/ccd.27825] [PMID: 30196572]
[110]
Ormiston JA, De Vroey F, Serruys PW, Webster MWI. Bioresorbable polymeric vascular scaffolds: A cautionary tale. Circ Cardiovasc Interv 2011; 4(5): 535-8.
[http://dx.doi.org/10.1161/CIRCINTERVENTIONS.111.963710] [PMID: 22010192]
[111]
Jeger RV, Farah A, Ohlow MA, et al. BASKET-SMALL 2 Investigators. Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): An open-label randomised non-inferiority trial. Lancet 2018; 392(10150): 849-56.
[http://dx.doi.org/10.1016/S0140-6736(18)31719-7] [PMID: 30170854]
[112]
Merinopoulos I, Gunawardena T, Wickramarachchi U, Ryding A, Eccleshall S, Vassiliou VS. Percutaneous coronary intervention in the elderly: Are drug-coated balloons the future? Curr Cardiol Rev 2018; 14(1): 45-52.
[http://dx.doi.org/10.2174/1573403X14666171226144120] [PMID: 29278215]
[113]
Corballis NH, Wickramarachchi U, Vassiliou VS, Eccleshall SC. Duration of dual antiplatelet therapy in elective drug-coated balloon angioplasty. Catheter Cardiovasc Interv 2019; 1-5.
[http://dx.doi.org/10.1002/ccd.28632] [PMID: 31797532]
[114]
Komaru T, Isoyama S, Sekiguchi N, et al. Coronary angioplasty ameliorates hypoperfusion-induced endothelial dysfunction in patients with stable angina pectoris. J Am Coll Cardiol 1996; 27(1): 30-7.
[http://dx.doi.org/10.1016/0735-1097(95)00441-6] [PMID: 8522707]
[115]
Caramori PR, Lima VC, Seidelin PH, Newton GE, Parker JD, Adelman AG. Long-term endothelial dysfunction after coronary artery stenting. J Am Coll Cardiol 1999; 34(6): 1675-9.
[http://dx.doi.org/10.1016/S0735-1097(99)00411-8] [PMID: 10577555]
[116]
Togni M, Windecker S, Cocchia R, et al. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol 2005; 46(2): 231-6.
[http://dx.doi.org/10.1016/j.jacc.2005.01.062] [PMID: 16022947]
[117]
Togni M, Räber L, Cocchia R, et al. Local vascular dysfunction after coronary paclitaxel-eluting stent implantation. Int J Cardiol 2007; 120(2): 212-20.
[http://dx.doi.org/10.1016/j.ijcard.2006.09.021] [PMID: 17234280]
[118]
Knight DR, Shen YT, Young MA, Vatner SF. Acetylcholine-induced coronary vasoconstriction and vasodilation in tranquilized baboons. Circ Res 1991; 69(3): 706-13.
[http://dx.doi.org/10.1161/01.RES.69.3.706] [PMID: 1873865]
[119]
Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986; 315(17): 1046-51.
[http://dx.doi.org/10.1056/NEJM198610233151702] [PMID: 3093861]
[120]
Fuke S, Maekawa K, Kawamoto K, et al. Impaired endothelial vasomotor function after sirolimus-eluting stent implantation. Circ J 2007; 71(2): 220-5.
[http://dx.doi.org/10.1253/circj.71.220] [PMID: 17251671]
[121]
Kubo M, Miyoshi T, Oe H, Ohno Y, Nakamura K, Ito H. Prognostic significance of endothelial dysfunction in patients undergoing percutaneous coronary intervention in the era of drug-eluting stents. BMC Cardiovasc Disord 2015; 15(1): 102.
[http://dx.doi.org/10.1186/s12872-015-0096-z] [PMID: 26399321]
[122]
Gogas BD, Benham JJ, Hsu S, et al. Vasomotor function comparative assessment at 1 and 2 years following implantation of the absorb everolimus-eluting bioresorbable vascular scaffold and the xience V everolimus-eluting metallic stent in porcine coronary arteries: Insights from in vivo angiography, ex vivo assessment, and gene analysis at the stented/scaffolded segments and the proximal and distal edges. JACC Cardiovasc Interv 2016; 9(7): 728-41.
[http://dx.doi.org/10.1016/j.jcin.2015.12.018] [PMID: 27056313]
[123]
Serruys PW, Chevalier B, Sotomi Y, et al. Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): A 3 year, randomised, controlled, single-blind, multicentre clinical trial. Lancet 2016; 388(10059): 2479-91.
[http://dx.doi.org/10.1016/S0140-6736(16)32050-5] [PMID: 27806897]
[124]
Gomez-Lara J, Salvatella N, Romaguera R, et al. Collaborators. A randomized comparison of the coronary vasomotor function and myocardial flow in patients treated with everolimus-eluting bioresorbable scaffolds and everolimus-eluting metallic stents. EuroIntervention 2020; 16(2): e155-63.
[http://dx.doi.org/10.4244/EIJ-D-18-01203] [PMID: 31217148]
[125]
Sabaté M, Alfonso F, Cequier A, et al. Magnesium-based resorbable scaffold vs. permanent metallic sirolimus-eluting stent in patients with st-segment elevation myocardial infarction: the magstemi randomized clinical trial. Circulation 2019; 140(23): 1904-16.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.119.043467]
[126]
Cassese S, Byrne RA, Ndrepepa G, et al. Everolimus-eluting bioresorbable vascular scaffolds vs. everolimus-eluting metallic stents: A meta-analysis of randomised controlled trials. Lancet 2016; 387(10018): 537-44.
[http://dx.doi.org/10.1016/S0140-6736(15)00979-4] [PMID: 26597771]
[127]
Ludman PF. Percutaneous coronary intervention. Med (United Kingdom) 2018.
[http://dx.doi.org/10.1016/j.mpmed.2018.06.007]
[128]
Sousa-Uva M, Neumann FJ, Ahlsson A, et al. ESC/EACTS Guidelines on myocardial revascularization. Eur J Cardiothorac Surg 2018; 2019
[http://dx.doi.org/10.1093/ejcts/ezy289] [PMID: 30165632]

Rights & Permissions Print Cite
Article Metrics
26
1
© 2024 Bentham Science Publishers | Privacy Policy